Enveric Biosciences (ENVB) EBIT Margin (2014 - 2025)
Enveric Biosciences' EBIT Margin was -5.77% in Q3 2020, up 11.33 percentage points from -17.11% a year earlier and up 3.52 percentage points from the prior quarter.
Powered by 
Analysis
Enveric Biosciences (ENVB) EBIT Margin (2014 - 2025) Analysis & Trends
On a trailing twelve-month basis, Enveric Biosciences' EBIT Margin was -0.14% through Sep 30, 2020, up 36.66 percentage points year-over-year; for FY2019, it came in at -5.75%, up 10.87 percentage points from FY2018.
- EBIT Margin shows a four-year change of -1.83 percentage points (FY2015 to FY2019).
- In earlier years, EBIT Margin was -16.62% in FY2018 (+5.80 pp), -22.42% in FY2017 (-7.54 pp), -14.88% in FY2016 (-10.97 pp) and -3.92% in FY2015.
- Quarterly EBIT Margin has moved between -105.03% (Q4 2018) and 57.68% (Q3 2018) over five years.
- Compared with a year earlier, EBIT Margin has increased for four straight quarters, with an average year-over-year change of -1.10 percentage points over the last eight quarters.
- The best year-over-year quarter for EBIT Margin over five years was Q4 2019 (a gain of 127.57 percentage points); the worst was Q4 2018 (a drop of 76.99 percentage points).
- Per Business Quant data, ENVB's EBIT Margin in the three quarters before Q3 2020 was -9.30% (Q2 2020), -8.71% (Q1 2020) and 22.54% (Q4 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 28.37% |
| 10 | Enveric Biosciences | 6.02 Mn | -15.62 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -683,920.80% |
| Mar 31, 2025 | -67,267.31% |
| Jun 30, 2024 | -3,652.33% |
| Mar 31, 2024 | -5,362.62% |
| Dec 31, 2023 | -421,265.02% |
| Sep 30, 2023 | -154,152.66% |
| Jun 30, 2023 | -628,275.87% |
| Sep 30, 2020 | -5.77% |
| Jun 30, 2020 | -9.30% |
| Mar 31, 2020 | -8.71% |
| Dec 31, 2019 | 22.54% |
| Sep 30, 2019 | -17.11% |
| Jun 30, 2019 | -13.40% |
| Mar 31, 2019 | -12.15% |
| Dec 31, 2018 | -105.03% |
| Sep 30, 2018 | 57.68% |
| Jun 30, 2018 | -9.75% |
| Mar 31, 2018 | -12.35% |
| Dec 31, 2017 | -28.04% |
| Sep 30, 2017 | -31.49% |
API Access
Enveric Biosciences EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();